Cas no 3881-21-8 (2′-O-Methylinosine)
2′-O-Methylinosine Chemical and Physical Properties
Names and Identifiers
-
- 2'-O-Methylinosine
- 9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-3H-purin-6-one
- 2'-(O-METHYL)-INOSINE
- O2'-methyl-inosine
- 2′-O-Methylinosine
- 9-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-1H-purin-6(9H)-one
- AKOS025402340
- 9-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-9H-purin-6-ol
- HPHXOIULGYVAKW-IOSLPCCCSA-N
- DTXSID00435030
- Q15632692
- F87897
- A855621
- 2'-O-METHYL-D-INOSINE
- J-700080
- 9-[(2R,3R,4R,5R)-4-HYDROXY-5-(HYDROXYMETHYL)-3-METHOXYOXOLAN-2-YL]-1H-PURIN-6-ONE
- AC-8215
- 2'-O-Methyl-inosine
- CHEBI:68467
- NS00014739
- 3881-21-8
- MFCD01631008
- SCHEMBL658713
- DTXCID70385856
- DA-69613
-
- MDL: MFCD01631008
- Inchi: 1S/C11H14N4O5/c1-19-8-7(17)5(2-16)20-11(8)15-4-14-6-9(15)12-3-13-10(6)18/h3-5,7-8,11,16-17H,2H2,1H3,(H,12,13,18)/t5-,7-,8-,11-/m1/s1
- InChI Key: HPHXOIULGYVAKW-IOSLPCCCSA-N
- SMILES: O1[C@H](CO)[C@H]([C@H]([C@@H]1N1C=NC2C(NC=NC1=2)=O)OC)O
Computed Properties
- Exact Mass: 282.09600
- Monoisotopic Mass: 282.09641956g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 3
- Hydrogen Bond Acceptor Count: 9
- Heavy Atom Count: 20
- Rotatable Bond Count: 3
- Complexity: 420
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 4
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: -0.8
- Topological Polar Surface Area: 118?2
Experimental Properties
- Color/Form: No data avaiable
- Density: 1.8±0.1 g/cm3
- Melting Point: No data available
- Boiling Point: 724.3±60.0 °C at 760 mmHg
- Flash Point: 391.8±32.9 °C
- Refractive Index: 1.774
- Water Partition Coefficient: Slightly soluble in water.
- PSA: 122.49000
- LogP: -1.61480
- Vapor Pressure: 0.0±2.5 mmHg at 25°C
2′-O-Methylinosine Security Information
- Signal Word:warning
- Hazard Statement: H303+H313+H333
- Warning Statement: P264+P280+P305+P351+P338+P337+P313
- Safety Instruction: H303+H313+H333
- Storage Condition:Store at 4 ° C, -4 ° C is better
2′-O-Methylinosine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A159003076-10g |
9-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-9H-purin-6-ol |
3881-21-8 | 95% | 10g |
$503.28 | 2023-09-02 | |
| SHANG HAI YI EN HUA XUE JI SHU Co., Ltd. | R028643-1g |
2′-O-Methylinosine |
3881-21-8 | 99% | 1g |
¥1245 | 2024-05-23 | |
| SHANG HAI YI EN HUA XUE JI SHU Co., Ltd. | R028643-250mg |
2′-O-Methylinosine |
3881-21-8 | 99% | 250mg |
¥214 | 2024-05-23 | |
| SHANG HAI YI EN HUA XUE JI SHU Co., Ltd. | R028643-5g |
2′-O-Methylinosine |
3881-21-8 | 99% | 5g |
¥4809 | 2024-05-23 | |
| TRC | M313060-250mg |
2’-O-Methylinosine |
3881-21-8 | 250mg |
$207.00 | 2023-05-17 | ||
| TRC | M313060-500mg |
2’-O-Methylinosine |
3881-21-8 | 500mg |
$345.00 | 2023-05-17 | ||
| TRC | M313060-1g |
2’-O-Methylinosine |
3881-21-8 | 1g |
$ 455.00 | 2022-06-04 | ||
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | O99470-1g |
9-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-9H-purin-6-ol |
3881-21-8 | 1g |
¥878.0 | 2021-09-08 | ||
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | O99470-250mg |
9-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-9H-purin-6-ol |
3881-21-8 | 250mg |
¥218.0 | 2021-09-08 | ||
| Chemenu | CM138483-10g |
9-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-9H-purin-6-ol |
3881-21-8 | 95% | 10g |
$*** | 2023-05-30 |
2′-O-Methylinosine Suppliers
2′-O-Methylinosine Related Literature
-
Ernesto Abel-Santos,Tetyana Dodatko New J. Chem. 2007 31 748
-
2. Chapter 14. Nucleic acidsR. J. H. Davies Annu. Rep. Prog. Chem. Sect. B: Org. Chem. 1974 71 383
Related Categories
- Solvents and Organic Chemicals Organic Compounds Nucleosides, nucleotides, and analogues Purine nucleosides Purine nucleosides
- Solvents and Organic Chemicals Organic Compounds Nucleosides, nucleotides, and analogues Purine nucleosides
- Solvents and Organic Chemicals Organic Compounds Acids/Esters
- Other Chemical Reagents
Additional information on 2′-O-Methylinosine
Research Brief on 2′-O-Methylinosine (CAS: 3881-21-8): Recent Advances and Applications in Chemical Biology and Medicine
2′-O-Methylinosine (CAS: 3881-21-8) is a chemically modified nucleoside that has garnered significant attention in the fields of chemical biology and medicinal chemistry due to its unique properties and potential therapeutic applications. This research brief synthesizes the latest findings on this compound, focusing on its synthesis, biological activity, and emerging roles in drug development and RNA therapeutics.
Recent studies have highlighted the importance of 2′-O-Methylinosine in the context of RNA modification and its implications for mRNA stability and translation efficiency. A 2023 study published in Nucleic Acids Research demonstrated that 2′-O-Methylinosine incorporation into mRNA can significantly enhance its stability against nuclease degradation, making it a promising candidate for mRNA-based therapeutics and vaccines. The study employed advanced mass spectrometry techniques to characterize the metabolic pathways involved in the processing of this modified nucleoside.
In the realm of antiviral research, 2′-O-Methylinosine has shown particular promise. A team at Scripps Research Institute reported in Nature Chemical Biology (2024) that derivatives of 2′-O-Methylinosine exhibit potent inhibitory effects against certain RNA viruses by interfering with viral RNA replication mechanisms. The researchers utilized cryo-EM to visualize how these compounds interact with viral polymerases, providing atomic-level insights into their mechanism of action.
The synthetic chemistry of 2′-O-Methylinosine has also seen significant advancements. A recent publication in the Journal of Organic Chemistry (2024) described a novel, high-yield enzymatic synthesis route for 2′-O-Methylinosine that overcomes previous limitations in scalability. This development is particularly important for potential large-scale pharmaceutical applications, as it addresses previous challenges in the cost-effective production of this compound.
From a therapeutic perspective, preclinical studies have explored the potential of 2′-O-Methylinosine in cancer treatment. Research published in Molecular Cancer Therapeutics (2023) demonstrated that 2′-O-Methylinosine analogs can selectively inhibit the growth of certain cancer cell lines by disrupting oncogenic microRNA processing. The study employed comprehensive transcriptomic analysis to elucidate the molecular pathways affected by these compounds.
Looking forward, the unique properties of 2′-O-Methylinosine position it as a versatile building block for both therapeutic and diagnostic applications. Current research efforts are focusing on optimizing its pharmacokinetic properties and exploring its potential in combination therapies. As our understanding of RNA biology continues to expand, the applications of 2′-O-Methylinosine and related compounds are expected to grow significantly in the coming years.
3881-21-8 (2′-O-Methylinosine) Related Products
- 8075-88-5(Guanosine, mixt. with inosine (9CI))
- 503173-93-1(2',3'-Dideoxyinosine-1',2',3',4',5'-13C5)
- 38819-10-2(9-β-D-Arabinofuranosylguanine)
- 961-07-9(2'-Deoxyguanosine)
- 38559-49-8(2-amino-9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one)
- 70230-74-9(INOSINE, 3-METHYL-)
- 496809-83-7(Inosine, 5'-azido-2',5'-dideoxy-)
- 478511-34-1(Guanosine-5',5''-d2 Monohydrate)
- 85421-89-2(6H-Purin-6-one,2-amino-9-(6-deoxy-b-D-allofuranosyl)-1,9-dihydro-)
- 68768-32-1(GUANOSINE, 3-METHYL-)